{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:20:43Z","timestamp":1792196443497,"version":"4.4.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP1 DA039543"],"award-info":[{"award-number":["DP1 DA039543"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM007270"],"award-info":[{"award-number":["T32 GM007270"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31 AI165168"],"award-info":[{"award-number":["F31 AI165168"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD103571"],"award-info":[{"award-number":["R01 HD103571"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.celrep.2023.112556","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T19:14:14Z","timestamp":1684869254000},"page":"112556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T\u00a0cells"],"prefix":"10.1016","volume":"42","author":[{"given":"Hannah L.","family":"Itell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Humes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Overbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112556_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2023.112556_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00002030-198903010-00006","article-title":"HIV replication can be blocked by recombinant human interferon beta","volume":"3","author":"Michaelis","year":"1989","journal-title":"AIDS"},{"key":"10.1016\/j.celrep.2023.112556_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.1986.6.143","article-title":"Human alpha- and beta-interferon but not gamma- suppress the in\u00a0vitro replication of LAV, HTLV-III, and ARV-2","volume":"6","author":"Yamamoto","year":"1986","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.celrep.2023.112556_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.1991.11.313","article-title":"Multiple effects of interferon on HIV-1 replication","volume":"11","author":"Pitha","year":"1991","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.celrep.2023.112556_bib5","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1128\/JVI.00854-10","article-title":"Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T\u00a0cells","volume":"84","author":"Goujon","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib6","doi-asserted-by":"crossref","first-page":"e1005254","DOI":"10.1371\/journal.ppat.1005254","article-title":"Interferon-alpha subtypes in an ex\u00a0vivo model of acute HIV-1 infection: expression, potency and effector mechanisms","volume":"11","author":"Harper","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112556_bib7","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/652420","article-title":"Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial","volume":"201","author":"Asmuth","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112556_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jis663","article-title":"Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration","volume":"207","author":"Azzoni","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112556_bib9","doi-asserted-by":"crossref","first-page":"eaat0843","DOI":"10.1126\/sciadv.aat0843","article-title":"CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans","volume":"4","author":"El-Diwany","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2023.112556_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/infdis\/jis211","article-title":"Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a","volume":"205","author":"Hubbard","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112556_bib11","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/aid.1991.7.375","article-title":"Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection","volume":"7","author":"von Sydow","year":"1991","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.celrep.2023.112556_bib13","doi-asserted-by":"crossref","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","article-title":"HIV restriction factors and mechanisms of evasion","volume":"2","author":"Malim","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.celrep.2023.112556_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrmicro3449","article-title":"HIV-1 and interferons: who's interfering with whom?","volume":"13","author":"Doyle","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2023.112556_bib15","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3389\/fimmu.2018.02876","article-title":"Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1","volume":"9","author":"Colomer-Lluch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112556_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nri3295","article-title":"Evolutionary conflicts between viruses and restriction factors shape immunity","volume":"12","author":"Duggal","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2023.112556_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"Stremlau","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chom.2010.06.004","article-title":"Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses","volume":"8","author":"Kirchhoff","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112556_bib19","doi-asserted-by":"crossref","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.celrep.2023.112556_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.chom.2019.05.002","article-title":"IFI16 targets the transcription factor Sp1 to suppress HIV-1 transcription and latency reactivation","volume":"25","author":"Hotter","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112556_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12542","article-title":"Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection","volume":"502","author":"Goujon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib22","doi-asserted-by":"crossref","first-page":"e39823","DOI":"10.7554\/eLife.39823","article-title":"A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV","volume":"7","author":"OhAinle","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112556_bib23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.chom.2016.02.019","article-title":"Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity","volume":"19","author":"Krapp","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112556_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature11433","article-title":"Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11","volume":"491","author":"Li","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib25","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2014.11.001","article-title":"IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread","volume":"16","author":"Compton","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112556_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature12653","article-title":"MX2 is an interferon-induced inhibitor of HIV-1 infection","volume":"502","author":"Kane","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1742-4690-10-111","article-title":"90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1","volume":"10","author":"Lodermeyer","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.celrep.2023.112556_bib28","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/nm.3956","article-title":"MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins","volume":"21","author":"Tada","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112556_bib29","doi-asserted-by":"crossref","first-page":"e1000007","DOI":"10.1371\/journal.ppat.1000007","article-title":"The interferon response inhibits HIV particle production by induction of TRIM22","volume":"4","author":"Barr","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112556_bib30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41564-021-00960-6","article-title":"Author Correction: MX2-mediated innate immunity against HIV-1 is regulated by serine phosphorylation","volume":"6","author":"Betancor","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2023.112556_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.chom.2013.08.015","article-title":"The interferon-inducible MxB protein inhibits HIV-1 infection","volume":"14","author":"Liu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112556_bib32","doi-asserted-by":"crossref","first-page":"e1003895","DOI":"10.1371\/journal.ppat.1003895","article-title":"Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals","volume":"10","author":"Pickering","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112556_bib33","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1128\/JVI.03146-15","article-title":"MxB is not responsible for the blocking of HIV-1 infection observed in alpha interferon-treated cells","volume":"90","author":"Opp","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1742-4690-9-55","article-title":"The function and evolution of the restriction factor Viperin in primates was not driven by lentiviruses","volume":"9","author":"Lim","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.celrep.2023.112556_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-014-0129-1","article-title":"The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB","volume":"12","author":"Liu","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.celrep.2023.112556_bib36","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1128\/JVI.73.7.5255-5264.1999","article-title":"Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties","volume":"73","author":"Poss","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib37","doi-asserted-by":"crossref","first-page":"e34420","DOI":"10.7554\/eLife.34420","article-title":"Mapping mutational effects along the evolutionary landscape of HIV envelope","volume":"7","author":"Haddox","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112556_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0042-6822(91)90537-L","article-title":"Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI","volume":"185","author":"Peden","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2023.112556_bib39","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","author":"Bolen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2023.112556_bib40","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib41","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41564-019-0592-5","article-title":"Cyclophilin A protects HIV-1 from restriction by human TRIM5alpha","volume":"4","author":"Kim","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2023.112556_bib42","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.celrep.2020.02.100","article-title":"Cyclophilin A prevents HIV-1 restriction in lymphocytes by blocking human TRIM5alpha binding to the viral core","volume":"30","author":"Selyutina","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112556_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.chom.2016.08.006","article-title":"Resistance of transmitted founder HIV-1 to IFITM-mediated restriction","volume":"20","author":"Foster","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112556_bib44","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41467-022-29346-w","article-title":"A functional map of HIV-host interactions in primary human T\u00a0cells","volume":"13","author":"Hiatt","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112556_bib45","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1128\/JVI.00458-16","article-title":"Complex interplay between HIV-1 capsid and MX2-independent alpha interferon-induced antiviral factors","volume":"90","author":"Bulli","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib46","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1128\/JVI.00214-14","article-title":"Host and viral determinants of Mx2 antiretroviral activity","volume":"88","author":"Busnadiego","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib47","doi-asserted-by":"crossref","first-page":"e35738","DOI":"10.7554\/eLife.35738","article-title":"Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2","volume":"7","author":"Kane","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112556_bib48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12977-014-0090-z","article-title":"Host and viral determinants for MxB restriction of HIV-1 infection","volume":"11","author":"Matreyek","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.celrep.2023.112556_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.omtm.2020.10.020","article-title":"The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T\u00a0cells","volume":"20","author":"Humes","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.celrep.2023.112556_bib50","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","article-title":"Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112556_bib51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.20171626","article-title":"Optimized RNP transfection for highly efficient CRISPR\/Cas9-mediated gene knockout in primary T\u00a0cells","volume":"215","author":"Seki","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112556_bib52","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41592-018-0149-1","article-title":"Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells","volume":"15","author":"Ting","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.112556_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41596-018-0113-7","article-title":"Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute","volume":"14","author":"Wang","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2023.112556_bib54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/eji.201344412","article-title":"NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infection","volume":"45","author":"Ranjan","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2023.112556_bib55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41592-021-01328-8","article-title":"Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4(+) T\u00a0cells allows complex functional analyses","volume":"19","author":"Albanese","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.112556_bib56","doi-asserted-by":"crossref","first-page":"16068","DOI":"10.1038\/nmicrobiol.2016.68","article-title":"HIV-host interactome revealed directly from infected cells","volume":"1","author":"Luo","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2023.112556_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature10719","article-title":"Global landscape of HIV-human protein complexes","volume":"481","author":"J\u00e4ger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib58","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1126\/science.1070925","article-title":"Identification of signal peptide peptidase, a presenilin-type aspartic protease","volume":"296","author":"Weihofen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112556_bib59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20091005","article-title":"Signal peptide peptidase (SPP) assembles with substrates and misfolded membrane proteins into distinct oligomeric complexes","volume":"427","author":"Schrul","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.celrep.2023.112556_bib60","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1093\/emboj\/cdf414","article-title":"Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets","volume":"21","author":"McLauchlan","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2023.112556_bib61","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1073\/pnas.0704894104","article-title":"Cellular cofactors affecting hepatitis C virus infection and replication","volume":"104","author":"Randall","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112556_bib62","doi-asserted-by":"crossref","first-page":"e1010898","DOI":"10.1371\/journal.ppat.1010898","article-title":"Knockout of signal peptide peptidase in the eye reduces HSV-1 replication and eye disease in ocularly infected mice","volume":"18","author":"Wang","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112556_bib63","doi-asserted-by":"crossref","first-page":"e85360","DOI":"10.1371\/journal.pone.0085360","article-title":"Binding of HSV-1 glycoprotein K (gK) to signal peptide peptidase (SPP) is required for virus infectivity","volume":"9","author":"Allen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112556_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nature18631","article-title":"Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens","volume":"535","author":"Marceau","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib65","doi-asserted-by":"crossref","first-page":"e32942","DOI":"10.7554\/eLife.32942","article-title":"Single-cell transcriptional dynamics of flavivirus infection","volume":"7","author":"Zanini","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112556_bib66","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1515\/BC.2006.191","article-title":"Leucine aminopeptidases: diversity in structure and function","volume":"387","author":"Matsui","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.celrep.2023.112556_bib67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1756-8722-6-72","article-title":"IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells","volume":"6","author":"Chen","year":"2013","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.celrep.2023.112556_bib68","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.celrep.2014.12.047","article-title":"Differential regulation of NF-kappaB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins","volume":"10","author":"Sauter","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112556_bib69","doi-asserted-by":"crossref","first-page":"E4571","DOI":"10.1073\/pnas.1311669110","article-title":"IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication","volume":"110","author":"Jakobsen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112556_bib70","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1038\/ncomms14391","article-title":"IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP","volume":"8","author":"J\u00f8nsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112556_bib71","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1243640","article-title":"IFI16 DNA sensor is required for death of lymphoid CD4 T\u00a0cells abortively infected with HIV","volume":"343","author":"Monroe","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112556_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jir.2010.0110","article-title":"Interferon-stimulated gene 15 and the protein ISGylation system","volume":"31","author":"Zhang","year":"2011","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.celrep.2023.112556_bib73","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1128\/JVI.02478-09","article-title":"The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process","volume":"84","author":"Pincetic","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib74","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.celrep.2018.01.091","article-title":"Large-scale arrayed analysis of protein degradation reveals cellular targets for HIV-1 Vpu","volume":"22","author":"Jain","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112556_bib75","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1073\/pnas.1619640114","article-title":"Delta20 IFITM2 differentially restricts X4 and R5 HIV-1","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112556_bib76","doi-asserted-by":"crossref","first-page":"854974","DOI":"10.3389\/fmicb.2022.854974","article-title":"HIV capsid protein genetic diversity across HIV-1 variants and impact on new capsid-inhibitor lenacapavir","volume":"13","author":"Troyano-Hern\u00e1ez","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.celrep.2023.112556_bib77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112556_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41596-018-0069-7","article-title":"CRISPR-Cas9 genome engineering of primary CD4(+) T\u00a0cells for the interrogation of HIV-host factor interactions","volume":"14","author":"Hultquist","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2023.112556_bib79","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.celrep.2016.09.080","article-title":"A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T\u00a0cells","volume":"17","author":"Hultquist","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112556_bib83","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2023.112556_bib84","doi-asserted-by":"crossref","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","article-title":"ComBat-seq: batch effect adjustment for RNA-seq count data","volume":"2","author":"Zhang","year":"2020","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.celrep.2023.112556_bib87","series-title":"Ggpubr: \u2018ggplot2' Based Publication Ready Plots","author":"Kassambara","year":"2023"},{"key":"10.1016\/j.celrep.2023.112556_bib80","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JVI.80.2.835-844.2006","article-title":"Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant","volume":"80","author":"Wu","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112556_bib81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1126\/science.3014648","article-title":"The role of mononuclear phagocytes in HTLV-III\/LAV infection","volume":"233","author":"Gartner","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112556_bib82","doi-asserted-by":"crossref","first-page":"e50859","DOI":"10.1371\/journal.pone.0050859","article-title":"Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors","volume":"7","author":"Vermeire","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112556_bib85","doi-asserted-by":"crossref","first-page":"W171","DOI":"10.1093\/nar\/gkz365","article-title":"CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing","volume":"47","author":"Labun","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2023.112556_bib86","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nmeth.4423","article-title":"GUIDES: sgRNA design for loss-of-function screens","volume":"14","author":"Meier","year":"2017","journal-title":"Nat. Methods"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723005673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723005673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T17:57:46Z","timestamp":1720720666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723005673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2211124723005673"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112556","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.07.527545","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T\u00a0cells","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"112556"}}